WEBINAR: Know Your Options: Empowering Patients Through Innovation
An expert-led session that offers food allergy patients and caregivers valuable insights into emerging treatments, management options, and practical steps to improve daily life with food allergy.
Wednesday, March 25, 2026, 12:30 p.m.–1:30 p.m. ET
Food allergy impacts millions around the globe, and recent advancements in treatment options are giving patients and families more choices than ever before to manage their condition. Join us for a webinar on March 25, at 12:30 p.m. ET, in which Dr. Sharon Chinthrajah will unveil the latest innovations in allergy management, cutting-edge therapies, and what the future holds for those affected by food allergy.
Caregivers and families will gain valuable insights into emerging treatments, personalized management strategies, and practical steps to improve daily life with food allergy. Learn how to better understand your options, partner with your healthcare team, and make informed decisions that support safety, confidence, and quality of life.
About the Speakers
R. Sharon Chinthrajah, MD
R. Sharon Chinthrajah, M.D. is an Associate Professor and the Co-Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. Dr. Chinthrajah received her MD from Drexel University College of Medicine, completed her Internal Medicine training and a chief residency at California Pacific Medical Center, and sub-specialized in Pulmonary/Critical Care and Allergy/Immunology at Boston Medical Center. Her research is focused on developing novel therapeutic options for allergic diseases as well as unraveling the molecular mechanisms driving therapeutic response. She has extensive experience in performing both academic and industry-sponsored clinical trials investigating allergic diseases such as food allergy, atopic dermatitis, eosinophilic esophagitis, asthma, and COVID-19. Her research has led to the publication of over 160 research articles in peer-reviewed journals, including studies that led to the FDA approval of omalizumab for the treatment of food allergy. She is dedicated to training the next generation of clinical researchers and continues to act as a mentor for students and junior faculty interested in pursuing medical research.
This webinar is sponsored by Genentech, a Member of the Roche Group.
